Sex determination and sexual differentiation pathways are highly conserved between marsupials and eutherians. There are 2 different pathways of prostaglandin D2 (PGD2) synthesis: prostaglandin D synthase (PTGDS) and haematopoietic prostaglandin D synthase (HPGDS). PGD2 regulates the subcellular localization of SOX9 during gonadal sexual differentiation. To investigate the function of PGD2 in the tammar gonad, we cultured undifferentiated male gonads in the presence of the HPGDS inhibitor HQL-79 and female gonads with exogenous PGD2 to mimic activation of the PTGDS-PGD2 pathway. Tammar PTGDS and HPGDS have only 50% similarity with mouse and human orthologues, but functional domains are conserved. The expression of SOX9 was unchanged by the treatments in cultured gonads, but its subcellular localization was markedly affected. SOX9 remained cytoplasmic in the Sertoli cells of testes treated with HQL-79. Treated testes developed a thickened ovary-like surface epithelium. In contrast, SOX9 became nuclear in the granulosa cells of developing ovaries treated with PGD2 and the surface epithelium was thin, as in testes. These results demonstrate that PGD2 regulates the subcellular localization of SOX9 and subsequent gonadal development in the developing marsupial gonads, as it does in mice, and that it must have been an ancestral mechanism.

Keywords:
Marsupial, Testes, Ovaries, Sexual differentiation, Tammar wallaby
1.
Adams IR, McLaren A: Sexually dimorphic development of mouse primordial germ cells: switching from oogenesis to spermatogenesis. Development 129:1155-1164 (2002).
2.
Aithal MGS, Rajeswari N: Validation of housekeeping genes for gene expression analysis in glioblastoma using quantitative real-time polymerase chain reaction. Brain Tumor Res Treat 3:24-29 (2015).
3.
Aritake K, Kado Y, Inoue T, Miyano M, Urade Y: Structural and functional characterization of HQL-79, an orally selective inhibitor of human hematopoietic prostaglandin D synthase. J Biol Chem 281:15277-15286 (2006).
4.
Barber RD, Harmer DW, Coleman RA, Clark BJ: Gapdh as a housekeeping gene: analysis of Gapdh mRNA expression in a panel of 72 human tissues. Physiol Genomics 21:389-395 (2005).
5.
Bininda-Emonds ORP, Cardillo M, Jones KE, MacPhee RDE, Beck RMD, et al: The delayed rise of present-day mammals. Nature 446:507-512 (2007).
6.
Chung JW, Pask AJ, Yu H, Renfree MB: Fibroblast growth factor-9 in marsupial testicular development. Sex Dev 5:131-140 (2011).
7.
De Santa Barbara P, Moniot B, Poulat F, Berta P: Expression and subcellular localization of SF-1, SOX9, WT1, and AMH proteins during early human testicular development. Dev Dyn 217:293-298 (2000).
8.
Gonen N, Quinn A, O'Neill HC, Koopman P, Lovell-Badge R: Normal levels of Sox9 expression in the developing mouse testis depend on the TES/TESCO enhancer, but this does not act alone. PLoS Genet 13:e1006520 (2017).
9.
Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J: Qbase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 8:R19 (2007).
10.
Hutson JM, Shaw G, Short RV, Renfree MB: Mullerian inhibiting substance production and testicular migration and descent in the pouch young of a marsupial. Development 104:549-556 (1988).
11.
Jameson SA, Lin YT, Capel B: Testis development requires the repression of Wnt4 by Fgf signaling. Dev Biol 370:24-32 (2012).
12.
Kim Y, Kobayashi A, Sekido R, DiNapoli L, Brennan J, et al: Fgf9 and Wnt4 act as antagonistic signals to regulate mammalian sex determination. PLoS Biol 4:e187 (2006).
13.
Luo Z-X, Yuan C-X, Meng Q-J, Ji Q: A jurassic eutherian mammal and divergence of marsupials and placentals. Nature 476:442-445 (2011).
14.
Malki S, Nef S, Notarnicola C, Thevenet L, Gasca S, et al: Prostaglandin D2 induces nuclear import of the sex-determining factor Sox9 via its cAMP-PKA phosphorylation. EMBO J 24:1798-1809 (2005).
15.
Marchler-Bauer A, Derbyshire MK, Gonzales NR, Lu S, Chitsaz F, et al: CDD: NCBI's conserved domain database. Nucleic Acids Res 43:D222-D226 (2015).
16.
Moniot B, Declosmenil F, Barrionuevo F, Scherer G, Aritake K, et al: The PGD2 pathway, independently of Fgf9, amplifies Sox9 activity in Sertoli cells during male sexual differentiation. Development 136:1813-1821 (2009).
17.
Moniot B, Farhat A, Aritake K, Declosmenil F, Nef S, et al: Hematopoietic prostaglandin D synthase (H-pgds) is expressed in the early embryonic gonad and participates to the initial nuclear translocation of the Sox9 protein. Dev Dyn 240:2335-2343 (2011).
18.
Nef S, Vassalli JD: Complementary pathways in mammalian female sex determination. J Biol 8:74 (2009).
19.
Nicholas KB, Nicholas HB, Deerfield DW: Genedoc: analysis and visualization of genetic variation. EMBNEW News 4:14 (1997).
20.
O W-S, Short RV, Renfree MB, Shaw G: Primary genetic control of somatic sexual differentiation in a mammal. Nature 331:716-717 (1988).
21.
Pask AJ, Renfree MB: Molecular regulation of marsupial reproduction and development, marsupial genetics and genomics, in Deakin JE, Waters PD, Graves JAM (eds): Marsupial Genetics and Genomics, pp 285-316 (Springer, New York 2010).
22.
Pask AJ, Harry JL, Graves JAM, O'Neill RJW, Layfield SL, et al: SOX9 has both conserved and novel roles in marsupial sexual differentiation. Genesis 33:131-139 (2002).
23.
Pask AJ, Whitworth DJ, Mao CA, Wei KJ, Sankovic N, et al: Marsupial anti-Mullerian hormone gene structure, regulatory elements, and expression. Biol Reprod 70:160-167 (2004).
24.
Pask AJ, Calatayud NE, Shaw G, Wood WM, Renfree MB: Oestrogen blocks the nuclear entry of SOX9 in the developing gonad of a marsupial mammal. BMC Biol 8:113 (2010).
25.
Renfree MB, Fletcher TP, Blanden DR, Lewis PR, Shaw G, et al: Physiological and behavioural events around the time of birth in macropodid marsupials. Kangaroos, Wallabies and Rat-kangaroos 1:323-337 (1989).
26.
Renfree MB, Harry JL, Shaw G, Josso N: The marsupial male: a role model for sexual development [and discussion]. Philos Trans R Soc Lond B Biol Sci 350:243-251 (1995).
27.
Schmahl J, Kim Y, Colvin JS, Ornitz DM, Capel B: Fgf9 induces proliferation and nuclear localization of Fgfr2 in Sertoli precursors during male sex determination. Development 131:3627-3636 (2004).
28.
Tyndale-Biscoe CH, Hinds LA: Seasonal patterns of circulating progesterone and prolactin and response to bromocriptine in the female tammar Macropus eugenii. Gen Comp Endocrinol 53:58-68 (1984).
29.
Wilhelm D, Martinson F, Bradford S, Wilson MJ, Combes AN, et al: Sertoli cell differentiation is induced both cell-autonomously and through prostaglandin signaling during mammalian sex determination. Dev Biol 287:111-124 (2005).
30.
Wilhelm D, Hiramatsu R, Mizusaki H, Widjaja L, Combes AN, et al: Sox9 regulates prostaglandin D synthase gene transcription in vivo to ensure testis development. J Biol Chem 282:10553-10560 (2007).
31.
Windley SP, Wilhelm D: Signaling pathways involved in mammalian sex determination and gonad development. Sex Dev 9:297-315 (2016).
32.
Wood JT, Carpenter SM, Poole WE: Confidence intervals for ages of marsupials determined from body measurements. Wildlife Res 8:269-274 (1981).
33.
Yu H, Pask AJ, Shaw G, Renfree MB: Differential expression of WNT4 in testicular and ovarian development in a marsupial. BMC Dev Biol 6:1 (2006).
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.